title: [Mesoglycan in acute and chronic venous insufficiency of the legs].
abstract: Fifty-eight patients with acute and chronic pathology of the lower limbs were treated with daily oral doses of 96 mg of mesoglycan, a drug having antithrombotic and fibrinolytic properties. After a 3-months trial both clinical picture and instrumental parameters were found to be improved.
authors.forename: V
authors.initials: V
authors.lastname: Sangrigoli
authors.forename: G
authors.initials: G
authors.lastname: Carrà
authors.forename: N
authors.initials: N
authors.lastname: Lazzara
authors.forename: F
authors.initials: F
authors.lastname: Micale
authors.forename: M G
authors.initials: MG
authors.lastname: Puleo
authors.forename: R
authors.initials: R
authors.lastname: Bonaccorsi
mesh_terms: D000208:Acute Disease; D000328:Adult; D002908:Chronic Disease; D005260:Female; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012039:Regional Blood Flow; D014463:Ultrasonography; D014689:Venous Insufficiency / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D006025:Glycosaminoglycans; C040617:mesoglycan
vernacular_title: Il mesoglicano nell'insufficienza venosa acuta e cronica degli arti inferiori.